Hepatitis C treatment of african americans: Difference between revisions

Jump to navigation Jump to search
(Created page with "{{Hepatitis C}} {{CMG}}; {{AOEIC}} {{VK}} ==Recommendations for Treatment of African Americans: AASLD Practice Guidelines 2009<ref name="pmid19554546">{{cite journal |author=...")
 
m (Changes made per Mahshid's request)
 
Line 16: Line 16:
[[Category:Hepatitis|C]]
[[Category:Hepatitis|C]]
[[Category:Gastroenterology]]
[[Category:Gastroenterology]]
[[Category:Infectious disease]]
 
[[Category:Disease]]
[[Category:Disease]]

Latest revision as of 17:56, 18 September 2017

Hepatitis Main Page

Hepatitis C

Home

Patient Info

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Epidemiology & Demographics

Risk Factors

Screening

Differentiating Hepatitis C from other Diseases

Natural History, Complications & Prognosis

Diagnosis

History & Symptoms

Physical Examination

Lab Tests

Electrocardiogram

Chest X Ray

CT

MRI

Ultrasound

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Future or Investigational Therapies

Hepatitis C treatment of african americans On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hepatitis C treatment of african americans

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hepatitis C treatment of african americans

CDC on Hepatitis C treatment of african americans

Hepatitis C treatment of african americans in the news

Blogs on Hepatitis C treatment of african americans

Directions to Hospitals Treating Hepatitis C

Risk calculators and risk factors for Hepatitis C treatment of african americans

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Varun Kumar, M.B.B.S. [2]

Recommendations for Treatment of African Americans: AASLD Practice Guidelines 2009[1]

1. African Americans infected with HCV who are appropriate treatment candidates should be treated with the current optimal regimen consisting of pegylated interferon and ribavirin (Class I, Level A).

2. African Americans with baseline neutropenia (ANC <1500 mm3) should not be excluded from hepatitis C treatment (Class IIa, Level B).

References

  1. Swan T, Curry J (2009). "Comment on the updated AASLD practice guidelines for the diagnosis, management, and treatment of hepatitis C: treating active drug users". Hepatology (Baltimore, Md.). 50 (1): 323–4, author reply 324–5. doi:10.1002/hep.23077. PMID 19554546. Retrieved 2012-02-21. Unknown parameter |month= ignored (help)

Template:WS Template:WH